Description
The CJC-1295 no DAC (5mg) and Ipamorelin (5mg) blend is a synergistic combination of two potent growth hormone secretagogues designed for research applications. CJC-1295, a synthetic analogue of growth hormone-releasing hormone (GHRH), stimulates the pituitary gland to release growth hormone in a sustained, pulsatile manner. This action mimics the body’s natural GH secretion patterns. Ipamorelin, a selective ghrelin receptor agonist, also stimulates the pituitary to release growth hormone, but through a different mechanism, leading to a more immediate and pronounced GH pulse.
The combination of these two peptides creates a powerful synergistic effect, amplifying the release of growth hormone for more significant research outcomes. Key research areas for this blend include studies on body composition, muscle growth, and cellular repair. The enhanced levels of GH and subsequently insulin-like growth factor 1 (IGF-1) are of interest in research exploring age-related decline, metabolic function, and tissue regeneration.
This product is intended for research purposes only and is not for human or animal consumption. All research should be conducted in a controlled laboratory setting.
CAS: CJC-1295: 863288-34-0; Ipamorelin: 170851-70-4
PubChem CID: CJC-1295: 91976842; Ipamorelin: 9831659
Molecular Formula: CJC-1295: C₁₅₂H₂₅₂N₄₄O₄₂; Ipamorelin: C₃₈H₄₉N₉O₅
Molecular Weight: CJC-1295: 3367.9 g/mol; Ipamorelin: 711.85 g/mol
Amino Acid Sequence: Blend – see individual components
Physical Form: Lyophilized Powder
Purity: ≥99% (each component)
Storage: -20°C, protected from light and moisture

